This is the first in a series of town halls featuring Joel M. Gelfand, MD, MSCE, and Leonard H. Calabrese, DO, who will discuss the latest knowledge and research on COVID-19. In this episode, they’re joined by Carlos del Rio, MD, who discusses the use of booster shots in the general population and in patients with underlying autoimmunity.

• Welcome from Joel Gelfand, MD, MSCE :10
• About Calabrese, del Rio and Gelfand :30
• del Rio on the future of the pandemic 1:12
• Recommendations for boosters in general population 3:25
• What does “immunocompromised” mean in terms of boosters? 6:14
• What is an additional dose vs. booster dose? Who’s eligible? 9:24
• Summary 14:12
• Immunosuppressed patients – degree of severity 16:14
• Safety of boosters in general population 17:00
• Safety of boosters in those with underlying autoimmunity 18:12
• Questions from the audience 22:03
• Tweet your questions @DrJoelGelfand, @LCalabreseDO and @CarlosdelRio7 29:24

We’d love to hear from you! Send your comments/questions to Drs. Gelfand, Calabrese and del Rio at [email protected]. Be sure to check Healio.com/coronavirus for daily updates on the pandemic and follow us on Twitter @InfectDisNews, @GoHealio, @DrJoelGelfand, @LCalabreseDO and @CarlosdelRio7.